Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer's disease
- PMID: 23875003
- PMCID: PMC3714252
- DOI: 10.1371/journal.pone.0069830
Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer's disease
Erratum in
- PLoS One. 2014;9(12):e116442
Abstract
Alzheimer's disease is a progressive neurodegenerative disease that entails impairments of memory, thinking and behavior and culminates into brain atrophy. Impaired glucose uptake (accumulating into energy deficits) and synaptic plasticity have been shown to be affected in the early stages of Alzheimer's disease. This study examines the ability of lipoic acid to increase brain glucose uptake and lead to improvements in synaptic plasticity on a triple transgenic mouse model of Alzheimer's disease (3xTg-AD) that shows progression of pathology as a function of age; two age groups: 6 months (young) and 12 months (old) were used in this study. 3xTg-AD mice fed 0.23% w/v lipoic acid in drinking water for 4 weeks showed an insulin mimetic effect that consisted of increased brain glucose uptake, activation of the insulin receptor substrate and of the PI3K/Akt signaling pathway. Lipoic acid supplementation led to important changes in synaptic function as shown by increased input/output (I/O) and long term potentiation (LTP) (measured by electrophysiology). Lipoic acid was more effective in stimulating an insulin-like effect and reversing the impaired synaptic plasticity in the old mice, wherein the impairment of insulin signaling and synaptic plasticity was more pronounced than those in young mice.
Conflict of interest statement
Figures
References
-
- Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K et al. (2006) Association between CSF biomarkers and incipient Alzheimer s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5: 228-234. - PubMed
-
- Brinton RD (2008) Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer’s disease. Adv Drug Deliv Rev 60: 1504-1511. doi:10.1016/j.addr.2008.06.003. PubMed: 18647624. - DOI - PMC - PubMed
-
- Swerdlow RH (2011) Brain aging, Alzheimer’s disease, and mitochondria. Biochim Biophys Acta 1812: 1630-1639. doi:10.1016/j.bbadis.2011.08.012. PubMed: 21920438. - DOI - PMC - PubMed
-
- Swerdlow RH, Khan SM (2004) A "mitochondrial cascade hypothesis" for sporadic Alzheimer’s disease. Med Hypotheses 63: 8-20. doi:10.1016/j.mehy.2003.12.045. PubMed: 15193340. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
